Search

everythinglearnresearchcommunity

for

Search:↓

A mix of specific inhibitors and a growth factor helps keep hair growth cells from losing their properties in the lab.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

γδT cells can protect hair follicles from alopecia areata and promote hair regrowth.

LED light therapy at 863 nm wavelength can slow down skin tumor growth and reduce inflammation in mice.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

JAK inhibitors show promise in treating difficult skin diseases.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

Targeting NETs may help reduce fibrosis in Crohn's disease.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

BMS-470539 reduces skin fibrosis and inflammation.

The patch effectively promotes hair growth for alopecia areata without pain.

Immune checkpoint inhibitors can cause scalp inflammation and hair follicle issues.

Baricitinib is widely used for several conditions, especially COVID-19, but its safety and effectiveness are still being evaluated.

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

A DNA aptamer helps promote hair growth by enhancing a key cell growth signal in hair follicle cells.

miR-22 helps skin cancer grow and spread by activating specific cell signals.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Adalimumab effectively stabilized severe folliculitis decalvans, preventing further hair loss and inflammation.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Dupilumab helped a 13-year-old regrow hair after alopecia totalis.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Targeting the Smoothened receptor shows promise for treating certain cancers.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.